Modulation of T lymphocyte function by the pregnane X receptor

Journal of Immunology

Volumn 184, Issue 6, 2010, Pages 2949-2957

  Dubrac, Sandrine ^a   Elentner, Andreas ^a   Ebner, Susanne ^a,b   Horejs Hoeck, Jutta ^c   Schmuth, Matthias ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b Oncotyrol Center for Personalized Cancer Medicine   (Austria)

^c UNIVERSITY OF SALZBURG   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR ALPHA; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; PREGNANE X RECEPTOR; SUPPRESSOR OF CYTOKINE SIGNALING 1; TRANSCRIPTION FACTOR T BET; GROWTH INHIBITOR; STEROID RECEPTOR;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOMODULATION; IMMUNOREGULATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; CELL DIFFERENTIATION; CYTOLOGY; DRUG ANTAGONISM; DRUG POTENTIATION; GENETICS; IMMUNOLOGY; LEUKEMIA CELL LINE; LYMPHOCYTE ACTIVATION; METABOLISM; MOUSE MUTANT; PHYSIOLOGY; UPREGULATION;

ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; GROWTH INHIBITORS; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; JURKAT CELLS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, STEROID; T-LYMPHOCYTES; UP-REGULATION;

EID: 77951929675     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0902151     Document Type: Article

References (42)

1. Rosenfeld, J. M., R. Vargas, Jr., W. Xie, and R. M. Evans. 2003. Genetic profiling defines the xenobiotic gene network controlled by the nuclear receptor pregnane X receptor. Mol. Endocrinol. 17: 1268-1282.
2. Kliewer, S. A., B. Goodwin, and T. M. Willson. 2002. The nuclear pregnane X receptor: a key regulator of xenobiotic metabolism. Endocr. Rev. 23: 687-702.
3. Lehmann, J. M., D. D. McKee, M. A. Watson, T. M. Willson, J. T. Moore, and S. A. Kliewer. 1998. The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. J. Clin. Invest. 102: 1016-1023.
4. Zhang, J., P. Kuehl, E. D. Green, J. W. Touchman, P. B. Watkins, A. Daly, S. D. Hall, P. Maurel, M. Relling, C. Brimer, et al. 2001. The human pregnane X receptor: genomic structure and identification and functional characterization of natural allelic variants. Pharmacogenetics 11: 555-572.
5. Goodwin, B., M. R. Redinbo, and S. A. Kliewer. 2002. Regulation of cyp3a gene transcription by the pregnane x receptor. Annu. Rev. Pharmacol. Toxicol. 42: 1-23.
6. Schote, A. B., J. D. Turner, J. Schiltz, and C. P. Muller. 2007. Nuclear receptors in human immune cells: expression and correlations. Mol. Immunol. 44: 1436-1445.
7. Siest, G., E. Jeannesson, J. B. Marteau, A. Samara, B. Marie, M. Pfister, and S. Visvikis-Siest. 2008. Transcription factor and drug-metabolizing enzyme gene expression in lymphocytes from healthy human subjects. Drug Metab. Dispos. 36: 182-189.
8. Paunescu, E. 1970. In vivo and in vitro suppression of humoral and cellular response by rifampicin. Nature 228: 1188-1189.
9. Nilsson, B. S. Rifampicin: an immunosuppressant? 1971. Lancet. 2: 374.
10. Tsankov, N., and I. Angelova. 2003. Rifampin in dermatology. Clin. Dermatol. 21: 50-55.
11. Mlambo, G., and L. B. Sigola. 2003. Rifampicin and dexamethasone have similar effects on macrophage phagocytosis of zymosan, but differ in their effects on nitrite and TNF-α production. Int. Immunopharmacol. 3: 513-522.
12. Ziglam, H. M., I. Daniels, and R. G. Finch. 2004. Immunomodulating activity of rifampicin. J. Chemother. 16: 357-361.
13. Tsankov, N., and M. Krasteva. 1993. On rifampin treatment of psoriasis. J. Am. Acad. Dermatol. 29: 1057.
14. Kzandjieva, J., J. Kamarashev, G. Hinkov, and N. Tsankov. 1997. Rifampicin and psoriasis. Akt. Dermatol 23: 78-81.
15. Tsankov, N., and I. Grozdev. 2009. Rifampicin in the treatment of psoriasis. J. Eur. Acad. Dermatol. Venereol. 23: 93-95.
16. Zhou, C., M. M. Tabb, E. L. Nelson, F. Grün, S. Verma, A. Sadatrafiei, M. Lin, S. Mallick, B. M. Forman, K. E. Thummel, and B. Blumberg. 2006. Mutual repression between steroid and xenobiotic receptor and NF-κB signaling pathways links xenobiotic metabolism and inflammation. J. Clin. Invest. 116: 2280-2289.
17. Shah, Y., X. Ma, K. Morimura, I. Kim, and F. J. Gonzalez. 2006. Pregnane X receptor activation ameliorates DSS-induced inflammatory bowel disease via inhibition of NF-κaB target gene expression. Am. J. Physiol. Gastrointest. Liver Physiol. 292: G1114-G1122.
18. Dring, M., C. Goulding, V. Trimble, D. Keegan, A. Ryan, K. Brophy, C. Smyth, P. Keeling, D. O'Donoghue, and M. O'Sullivan. 2006. The Pregnane X Receptor locus is associated with susceptibility to inflammatory bowel disease. Gastroenterology 130: 341-348.
19. Gu, X., S. Ke, D. Liu, T. Sheng, P. E. Thomas, A. B. Rabson, M. A. Gallo, W. Xie, and Y. Tian. 2006. Role of NF-κB in regulation of PXR-mediated gene expression: a mechanism for the suppression of cytochrome P-450 3A4 by proinflammatory agents. J. Biol. Chem. 281: 17882-17889.
20. Staudinger, J. L., B. Goodwin, S. A. Jones, D. Hawkins-Brown, K. I. MacKenzie, A. LaTour, Y. Liu, C. D. Klaassen, K. K. Brown, J. Reinhard, et al. 2001. The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity. Proc. Natl. Acad. Sci. USA 98: 3369-3374.
21. Dubrac, S., P. Stoitzner, D. Pirkebner, A. Elentner, K. Schoonjans, J. Auwerx, S. Saeland, P. Hengster, P. Fritsch, N. Romani, and M. Schmuth. 2007. Peroxisome proliferator-activated receptor-α activation inhibits Langerhans cell function. J. Immunol. 178: 4362-4372.
22. Ebner, S., S. Hofer, V. A. Nguyen, C. Fürhapter, M. Herold, P. Fritsch, C. Heufler, and N. Romani. 2002. A novel role for IL-3: human monocytes cultured in the presence of IL-3 and IL-4 differentiate into dendritic cells that produce less IL-12 and shift Th cell responses toward a Th2 cytokine pattern. J. Immunol. 168: 6199-6207. (Pubitemid 34620039)
23. Hebenstreit, D., P. Luft, A. Schmiedlechner, G. Regl, A. M. Frischauf, F. Aberger, A. Duschl, and J. Horejs-Hoeck. 2003. IL-4 and IL-13 induce SOCS-1 gene expression in A549 cells by three functional STAT6-binding motifs located upstream of the transcription initiation site. J. Immunol. 171: 5901-5907.
24. Barish, G. D., M. Downes, W. A. Alaynick, R. T. Yu, C. B. Ocampo, A. L. Bookout, D. J. Mangelsdorf, and R. M. Evans. 2005. A nuclear receptor atlas: macrophage activation. Mol. Endocrinol. 19: 2466-2477.
25. Muzio, M., J. Ni, P. Feng, and V. M. Dixit. 1997. IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling. Science 278: 1612-1615.
26. Muzio, M., G. Natoli, S. Saccani, M. Levrero, and A. Mantovani. 1998. The human toll signaling pathway: divergence of nuclear factor κB and JNK/SAPK activation upstream of tumor necrosis factor receptor-associated factor 6 (TRAF6). J. Exp. Med. 187: 2097-2101.
27. Yu, Y., H. Zeng, S. Lyons, A. Carlson, D. Merlin, A. S. Neish, and A. T. Gewirtz. 2003. TLR5-mediated activation of p38 MAPK regulates epithelial IL-8 expression via posttranscriptional mechanism. Am. J. Physiol. Gastrointest. Liver Physiol. 285: G282-G290.
28. Khan, M. A., J. Kang, and T. S. Steiner. 2004. Enteroaggregative Escherichia coli flagellin-induced interleukin-8 secretion requires Toll-like receptor 5-dependent p38 MAP kinase activation. Immunology 112: 651-660.
29. Bensinger, S. J., M. N. Bradley, S. B. Joseph, N. Zelcer, E. M. Janssen, M. A. Hausner, R. Shih, J. S. Parks, P. A. Edwards, B. D. Jamieson, and P. Tontonoz. 2008. LXR signaling couples sterol metabolism to proliferation in the acquired immune response. Cell 134: 97-111.
30. Szabo, S. J., S. T. Kim, G. L. Costa, X. Zhang, C. G. Fathman, and L. H. Glimcher. 2000. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100: 655-669.
31. Szabo, S. J., B. M. Sullivan, C. Stemmann, A. R. Satoskar, B. P. Sleckman, and L. H. Glimcher. 2002. Distinct effects of T-bet in TH1 lineage commitment and IFN-γ production in CD4 and CD8 T cells. Science 295: 338-342.
32. Zhang, J. G., D. Metcalf, S. Rakar, M. Asimakis, C. J. Greenhalgh, T. A. Willson, R. Starr, S. E. Nicholson, W. Carter, W. S. Alexander, et al. 2001. The SOCS box of suppressor of cytokine signaling-1 is important for inhibition of cytokine action in vivo. Proc. Natl. Acad. Sci. USA 98: 13261-13265.
33. Byers, V. S., and E. E. Sercarz. 1970. Induction and reversal of immune paralysis in vitro. J. Exp. Med. 132: 845-857.
34. Bellahsène, A., and A. Forsgren. 1980. Effect of rifampin on the immune response in mice. Infect. Immun. 27: 15-20.
35. Calleja, C., J. M. Pascussi, J. C. Mani, P. Maurel, and M. J. Vilarem. 1998. The antibiotic rifampicin is a nonsteroidal ligand and activator of the human glucocorticoid receptor. Nat. Med. 4: 92-96.
36. Ray, D. W., A. M. Lovering, J. R. Davis, and A. White. 1998. Rifampicin: a glucocorticoid receptor ligand? Nat. Med. 4: 1090-1091.
37. Jones, D. C., B. M. Manning, and R. A. Daynes. 2002. A role for the peroxisome proliferator-activated receptor α in T-cell physiology and ageing immunobiology. Proc. Nutr. Soc. 61: 363-369.
38. Liberman, A. C., D. Refojo, J. Druker, M. Toscano, T. Rein, F. Holsboer, and E. Arzt. 2007. The activated glucocorticoid receptor inhibits the transcription factor T-bet by direct protein-protein interaction. FASEB J. 21: 1177-1188.
39. Stephensen, C. B., R. Rasooly, X. Jiang, M. A. Ceddia, C. T. Weaver, R. A. Chandraratna, and R. P. Bucy. 2002. Vitamin A enhances in vitro Th2 development via retinoid X receptor pathway. J. Immunol. 168: 4495-4503.
40. Ryo, A., F. Suizu, Y. Yoshida, K. Perrem, Y. C. Liou, G. Wulf, R. Rottapel, S. Yamaoka, and K. P. Lu. 2003. Regulation of NF-κB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA. Mol. Cell 12: 1413-1426.
41. Bäck, M. 2007. Leukotriene receptors: crucial components in vascular inflammation. ScientificWorldJournal 7: 1422-1439.
42. Waxman, D. J. 1999. P450 gene induction by structurally diverse xenochemicals: central role of nuclear receptors CAR, PXR, and PPAR. Arch. Biochem. Biophys. 369: 11-23.